Results: 2

Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis

J. bras. nefrol; 40 (2), 2018
Abstract Hydralazine is a direct-acting vasodilator, which has been used in treatment for hypertension (HTN) since the 1950s. While it is well known to cause drug-induced lupus (DIL), recent reports are indicating the emergence of the drug-induced anti-neutrophil cytoplasmic antibody (ANCA) associated va...

Efecto de la hidralazina en la vasoconstricción hipóxica: su estudio en un modelo canino de atelectasia lobar
Effects of hydralazine on the hipoxic pulmonnary vasoconstriction

Con el objetivo de conocer si la hidralazina (H) es capaz de inhibir la vasoconstricción hipóxica (VCH) se estudio su efecto sobre el cortocircuito intrapulmonar (Qs) en el modelo experimental de otelectasia regional (A). Se analizaron en siete perros los cambios circulatorios pulmonares y los del inte...